Hong Kong, China

Wen Xiu Ni

This inventor holds 1 USPTO granted patent. Top assignees: City University of Hong Kong, Versitech, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wen Xiu Ni. Retrieved from https://idiyas.com/inventor/wen-xiu-ni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Wen Xiu Ni

Introduction

Wen Xiu Ni is a notable inventor based in Hong Kong, China. He has made significant strides in the field of cancer treatment through his innovative research and development. His work focuses on the creation of nitridoosmium complexes, which have potential applications in oncology.

Latest Patents

Wen Xiu Ni holds 1 patent for his invention titled "Nitridoosmium(VI) complexes for treatment of cancer." This patent relates to the development of nitridoosmium complexes and outlines methods for utilizing these compounds as effective treatments for cancer. His research contributes to the ongoing quest for more effective cancer therapies.

Career Highlights

Throughout his career, Wen Xiu Ni has been associated with prominent institutions such as the City University of Hong Kong and Versitech, Inc. His work in these organizations has allowed him to advance his research and collaborate with other experts in the field.

Collaborations

Wen Xiu Ni has worked alongside talented individuals, including Tai Chu Lau and Yun Wah Lam. Their collaborative efforts have further enriched the research landscape in which they operate.

Conclusion

Wen Xiu Ni's contributions to cancer treatment through his innovative nitridoosmium complexes highlight the importance of research and collaboration in the field of medicine. His work exemplifies the potential of scientific innovation to address critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…